Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
San Raffaele is internationally recognized for its integration of clinical care with cutting-edge research. It pioneered the world’s first approved ex vivo stem cell gene therapy for ADA-SCID (“Strimvelis”) and continues to develop innovative protocols in oncology and rare disease treatment. The center publishes extensively (>1,400 scientific publications/year) and treats highly complex cases with multidisciplinary teams using state-of-the-art technology such as Tomotherapy for radiotherapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Casa di Cura San Raffaele.